|
IT1288123B1
(it)
|
1996-09-04 |
1998-09-10 |
Nicox Sa |
Uso di nitroderivati per l'incontinenza urinaria
|
|
IT1303671B1
(it)
*
|
1998-07-28 |
2001-02-23 |
Nicox Sa |
Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
|
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
|
IT1311924B1
(it)
*
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
CA2393724A1
(en)
|
1999-12-23 |
2001-06-28 |
Nitromed, Inc. |
Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
|
|
CA2410632A1
(en)
|
2000-06-22 |
2001-12-27 |
David S. Garvey |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
IT1319202B1
(it)
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per le malattie a base infiammatoria.
|
|
IT1319201B1
(it)
*
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per il diabete.
|
|
JP4092203B2
(ja)
|
2000-12-21 |
2008-05-28 |
ニトロメッド，インク． |
新規のシクロオキシゲナーゼ２選択的阻害剤としての置換アリール化合物、組成物、および使用方法
|
|
NZ526540A
(en)
|
2000-12-25 |
2004-11-26 |
Sankyo Co |
Medicinal compositions containing aspirin and 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-flurobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine useful in preventing thrombus or embolus diseases
|
|
EP1219306A1
(en)
|
2000-12-29 |
2002-07-03 |
Nicox S.A. |
Compositions comprising cyclodextrins and NO- releasing drugs
|
|
CA2446064A1
(en)
|
2001-05-02 |
2002-11-07 |
Nitromed, Inc. |
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
|
|
ITMI20010985A1
(it)
*
|
2001-05-15 |
2002-11-15 |
Nicox Sa |
Farmaci per il morbo di alzheimer
|
|
SE0101702D0
(sv)
*
|
2001-05-15 |
2001-05-15 |
Ardenia Investments Ltd |
Novel potentiating compounds
|
|
DE10125883A1
(de)
|
2001-05-28 |
2002-12-12 |
Serumwerk Bernburg Ag |
Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
|
|
ITMI20011240A1
(it)
*
|
2001-06-13 |
2002-12-13 |
Nicox Sa |
Farmaci per le vasculopatie
|
|
ITMI20011307A1
(it)
*
|
2001-06-21 |
2002-12-21 |
Nicox Sa |
Farmaci per l'epilessia
|
|
ITMI20011744A1
(it)
*
|
2001-08-09 |
2003-02-09 |
Nicox Sa |
Farmaci per le vasculopatie
|
|
US7011854B2
(en)
|
2002-02-04 |
2006-03-14 |
Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
|
|
JP2005537223A
(ja)
*
|
2002-04-05 |
2005-12-08 |
ニトロメッド，インク． |
酸化窒素供与体、組成物および使用法
|
|
AU2003231255A1
(en)
|
2002-05-02 |
2003-12-31 |
Osteoscreen, Inc. |
Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate)
|
|
WO2003103602A2
(en)
|
2002-06-11 |
2003-12-18 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
ITMI20021399A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Inibitori della cicloossigenasi 2
|
|
ITMI20021392A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
|
|
ITMI20021391A1
(it)
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Nitroderivati di inibitori della cicloossigenasi-2
|
|
AU2003279622A1
(en)
|
2002-06-28 |
2004-01-19 |
Nitromed, Inc. |
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
|
|
CA2491127A1
(en)
|
2002-07-03 |
2004-01-15 |
Nitromed, Inc. |
Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
|
|
AU2003261281A1
(en)
|
2002-07-29 |
2004-02-16 |
Nicox S.A. |
Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
|
|
WO2004012659A2
(en)
|
2002-08-01 |
2004-02-12 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
|
ITMI20021861A1
(it)
*
|
2002-08-29 |
2004-02-29 |
Nicox Sa |
Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
|
|
US7166638B2
(en)
|
2003-05-27 |
2007-01-23 |
Nicox S.A. |
Statin derivatives
|
|
US7169805B2
(en)
|
2003-05-28 |
2007-01-30 |
Nicox S.A. |
Captopril derivatives
|
|
ATE424199T1
(de)
|
2003-06-19 |
2009-03-15 |
Nicox Sa |
Enalapril-nitroxy-derivate und verwandte verbindungen als ace-hemmer zur behandlung von kardiovaskulären erkrankungen
|
|
PL1653950T3
(pl)
*
|
2003-07-31 |
2008-08-29 |
Nicox Sa |
Pochodne nitrooksylowe losartanu, walsartanu, kandesartanu, telmisartanu, eprosartanu i olmesartanu jako antagonisty receptorów angiotensyny II do leczenia chorób sercowo-naczyniowych
|
|
RU2006119528A
(ru)
*
|
2003-12-02 |
2008-01-10 |
Никокс С.А. (Fr) |
Нитрооксипроизводные карведилола и других бета-блокаторов в качестве антигипертензивных средств
|
|
CA2554716A1
(en)
*
|
2004-01-22 |
2005-08-04 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated compounds, compositions and methods of use
|
|
US7067659B2
(en)
*
|
2004-04-23 |
2006-06-27 |
Duke University |
Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
|
|
AR054181A1
(es)
|
2004-08-26 |
2007-06-06 |
Nicholas Piramal India Ltd |
Prodrogas que contienen enlaces bio-divisibles. composiiciones farmaceuticas
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
US20070122509A1
(en)
*
|
2004-12-02 |
2007-05-31 |
Molecular Research Center, Inc. |
Antioxidant dietary supplement compositions and methods for maintaining healthy skin
|
|
US9579298B2
(en)
|
2004-12-02 |
2017-02-28 |
Piotr Chomczynski |
Antioxidant dietary supplement compositions and methods for maintaining healthy skin
|
|
EP1836160A1
(en)
*
|
2004-12-24 |
2007-09-26 |
CTG Pharma S.r.l. |
Compounds for treating metabolic syndrome
|
|
WO2007016677A2
(en)
*
|
2005-08-02 |
2007-02-08 |
Nitromed, Inc. |
Nitric oxide enhancing antimicrobial compounds, compositions and methods of use
|
|
CA2651851C
(en)
|
2006-05-19 |
2012-10-02 |
Mary Kay, Inc. |
Glyceryl and glycol acid compounds
|
|
DK2057139T3
(da)
*
|
2006-07-18 |
2013-11-18 |
Antibe Holdings Inc |
Hydrogensulfidderivater af non-steroide anti-inflammatoriske lægemidler
|
|
UA102216C2
(ru)
*
|
2006-07-18 |
2013-06-25 |
Антиб Терапьютикс Инк. |
4-гидрокситиобензамидные производной лекарственных веществ
|
|
TW200831079A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Angiotensin II receptor antagonists
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
EP2291182A1
(en)
*
|
2008-05-13 |
2011-03-09 |
Genmedica Therapeutics SL |
Salicylate conjugates useful for treating metabolic disorders
|
|
MD4009C2
(ro)
*
|
2008-07-15 |
2010-08-31 |
Институт Химии Академии Наук Молдовы |
Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
|
|
CA2775370A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Nitrogenix Inc. |
Nitric oxide releasing amino acid ester compound, composition and method of use
|
|
US7807716B2
(en)
*
|
2008-09-24 |
2010-10-05 |
Oral Delivery Technology Ltd. |
Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
|
|
US9085508B2
(en)
|
2008-09-24 |
2015-07-21 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester compound, composition and method of use
|
|
EP2194048A1
(en)
*
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
CN102421424A
(zh)
*
|
2009-03-16 |
2012-04-18 |
根梅迪卡治疗公司 |
用于治疗代谢性疾病的组合疗法
|
|
CA2755069A1
(en)
*
|
2009-03-16 |
2010-09-23 |
Genmedica Therapeutics Sl |
Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
|
|
CN102498088A
(zh)
*
|
2009-09-15 |
2012-06-13 |
帝斯曼知识产权资产管理有限公司 |
硝基氧基酯及其制备和用途
|
|
WO2011056561A1
(en)
|
2009-10-27 |
2011-05-12 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
WO2011057386A1
(en)
*
|
2009-11-13 |
2011-05-19 |
Oral Delivery Technology Ltd. |
Composition and prophylactic device for enhancing sexual performance or pleasure
|
|
IT1397212B1
(it)
*
|
2009-12-29 |
2013-01-04 |
Flamma Spa |
Derivati di amminoalcoli e loro attivita' terapeutica
|
|
AR081268A1
(es)
|
2010-06-02 |
2012-07-18 |
Cardiolynx Ag |
Derivados de nitrato de pioglitazona
|
|
CN102442908A
(zh)
*
|
2010-10-14 |
2012-05-09 |
天津药物研究院 |
制备萘普西诺的中间体及方法
|
|
GB201020811D0
(en)
*
|
2010-12-08 |
2011-01-19 |
Solvotrin Innovations Ltd |
Compounds
|
|
US8466197B2
(en)
|
2010-12-14 |
2013-06-18 |
Genmedica Therapeutics Sl |
Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
|
|
US9163044B2
(en)
|
2011-04-19 |
2015-10-20 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
|
WO2012149334A2
(en)
|
2011-04-27 |
2012-11-01 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
ES2628634T3
(es)
|
2011-07-21 |
2017-08-03 |
Alfama, Inc. |
Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
|
|
KR102158895B1
(ko)
|
2013-03-12 |
2020-09-22 |
마리 케이 인코포레이티드 |
보존 시스템
|
|
CA3042642A1
(en)
|
2013-08-12 |
2015-02-19 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
WO2015086838A2
(en)
*
|
2013-12-13 |
2015-06-18 |
Conaris Research Institute Ag |
A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
|
|
US10172797B2
(en)
|
2013-12-17 |
2019-01-08 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
JP2017509587A
(ja)
|
2013-12-27 |
2017-04-06 |
ノーバス・インターナショナル・インコーポレイテッドＮｏｖｕｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ，Ｉｎｃ． |
エトキシル化界面活性剤
|
|
CA2955229C
(en)
|
2014-07-17 |
2020-03-10 |
Pharmaceutical Manufacturing Research Services, Inc. |
Immediate release abuse deterrent liquid fill dosage form
|
|
ES2632808T3
(es)
|
2014-09-04 |
2017-09-15 |
Nicox Science Ireland |
Compuestos de carnosina donadores de óxido nítrico
|
|
WO2016064873A1
(en)
|
2014-10-20 |
2016-04-28 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended release abuse deterrent liquid fill dosage form
|
|
CN104478727A
(zh)
*
|
2014-12-22 |
2015-04-01 |
江西本草天工科技有限责任公司 |
一种阿魏酸释放一氧化氮的衍生物及其用途
|
|
CN105061286B
(zh)
*
|
2015-09-08 |
2017-11-24 |
上海蓝木化工有限公司 |
一种炔基取代吡咯类化合物的合成方法
|
|
US10584306B2
(en)
|
2017-08-11 |
2020-03-10 |
Board Of Regents Of The University Of Oklahoma |
Surfactant microemulsions
|
|
PL3588666T3
(pl)
|
2017-08-14 |
2022-10-10 |
Lg Energy Solution, Ltd. |
Pakiet akumulatorowy o ulepszonych parametrach kontroli temperatury
|
|
WO2019074870A1
(en)
*
|
2017-10-09 |
2019-04-18 |
The Broad Institute, Inc. |
COMPOSITIONS AND METHODS FOR DISCOVERING COMBINATORY DRUG IN DROPLETS OF THE NANOLITRE ORDER
|
|
CN109942455A
(zh)
*
|
2019-03-10 |
2019-06-28 |
陕西科技大学 |
具有抗肿瘤活性的棉酚-依氟鸟氨酸席夫碱化合物及其合成方法
|
|
CN111087301B
(zh)
*
|
2019-12-23 |
2022-05-20 |
河南中医药大学 |
布洛芬咖啡酸酯的合成方法及其在制备免疫抑制药物中的应用
|
|
CN111087302B
(zh)
*
|
2019-12-23 |
2022-05-20 |
河南中医药大学 |
布洛芬阿魏酸酯的合成方法及其在制备免疫抑制药物中的应用
|
|
CN116744904A
(zh)
*
|
2020-12-24 |
2023-09-12 |
参天制药株式会社 |
含有依匹斯汀或其盐和硫系抗氧化剂的经皮施予用医药组合物
|
|
CN115500355B
(zh)
*
|
2022-09-09 |
2024-02-09 |
广东省农业科学院果树研究所 |
利用Podophyllotoxin和Gentisic acid防治荔枝霜疫霉病
|
|
US12564326B2
(en)
|
2022-10-25 |
2026-03-03 |
GE Precision Healthcare LLC |
Non-invasive bilirubin detection using induced photoreaction
|
|
CN116375698B
(zh)
*
|
2023-06-05 |
2023-08-01 |
中国林业科学研究院林产化学工业研究所 |
具有靶向抗肿瘤活性的漆酚基异羟肟酸型hdac抑制剂及其制备方法和应用
|